1430 / 1609
PORTEC 2 study
N=427
TAH+BSO
NO lymph node
dissection
Pelvic RT
46Gy / 23#
No brachytherapy
Vaginal
Brachytherapy
21Gy / 3# HDR
30Gy / 1# LDR
EBRT VBT
3 yr overall survival
84% 84%
p=0.55
3 yr disease specific survival
89% 89%
p=0.38
<50% MyInv
G3
>50% MyInv
G1, G2
IIA G1 G2